OZEM ETF — Roundhill GLP-1 & Weight Loss ETF
Roundhill GLP-1 & Weight Loss ETF (OZEM)
Updated October 2, 2026.
OZEM is an ETF linked to GLP-1 & weight-loss drug ecosystem (actively managed). its trailing-12-month yield is 1.37%, its expense ratio is 0.59%. Dividend Vision Distribution Safety Score™ is 50/100 (Unproven). Total return is 10.6% over the past 2.1 years, 35.6 points behind SPY at 46.2%.
Roundhill GLP-1 & Weight Loss ETF is an actively managed equity fund that invests at least 80% of its assets in companies involved in the GLP-1 and weight-loss drug ecosystem, including through derivative instruments, and is non-diversified. The fund has a modest current distribution rate with annual distributions and carries an expense ratio of 0.59%; note that the latest distribution was special and may not recur regularly. The fund appeals to investors seeking exposure to the GLP-1 and weight-loss pharmaceutical sector.
OZEM dividend yield and income
Price as of 2026-10-02.
Trailing-12-month yield (1.37%) is the last year of payments divided by the current price. The last dividend was $0.409914. The last ex-dividend date was 12/30/2025. It was paid on 12/31/2025.
| Ex-date | Amount | Change from previous payment |
|---|---|---|
| 2025-12-30 | $0.41 | 673.6% |
| 2024-12-30 | $0.053 | — |
| 2024 total (partial launch year) | $0.053 | — |
| 2025 total | $0.41 | — |
OZEM dividend growth
| Window | Change |
|---|---|
| 3Y | 0.0% |
| 5Y | 0.0% |
OZEM holdings and sector exposure
Holdings are not available for this snapshot.
OZEM performance versus SPY
Price and return data through 2026-10-02.
Total return is 10.6% over the past 2.1 years, 35.6 points behind SPY at 46.2%. Over the past year its total return — price change plus distributions reinvested — is 6.4%. Its deepest 1-year drawdown was 19.5%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -9.7% | — |
| 3M | -10.8% | — |
| 6M | -6.2% | — |
| YTD | -12.4% | — |
| 1Y | 6.4% | — |
| 2Y CAGR | — | 5.30% |
| Since inception (2.1 years) | 10.6% | 5.00% |
OZEM key facts
- Distribution Safety Score™
- 50 · Unproven
- Issuer
- Roundhill Investments
- Asset type
- ETF
- Asset class
- Equity
- Inception date
- 09/06/2024
- Expense ratio
- 0.59%
- Distribution frequency
- Annual
- Trailing yield
- 1.37%
- Last close
- $29.93 (as of 2026-10-02)
- AUM
- $56,641,883
- Average volume
- 9300.0
- Last dividend
- $0.409914
- Last ex-dividend date
- 12/30/2025
- Last payment date
- 12/31/2025
- Beta
- 0.0
- P/E ratio
- 16.308
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) is the latest regular payout annualized by the fund's stated frequency, divided by the last close. Issuers often publish this as “Distribution Rate” on the fact sheet. Trailing-12-month yield (1.37%) is the sum of distributions paid in the last 12 months, split-adjusted, divided by the last close. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: Roundhill Investments or company page; Index: GLP-1 & weight-loss drug ecosystem (actively managed); prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
OZEM risks and drawbacks
Payments are annual, so cash flow is lumpy versus a monthly fund. Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 19.5%.
Who may consider OZEM — and who may not
It is a weaker fit for investors who need monthly cash flow (OZEM pays annual); investors hunting double-digit covered-call yields; investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
Frequently asked questions
Does OZEM pay monthly?
No. OZEM currently pays annual, not monthly.
What is OZEM linked to?
OZEM is linked to GLP-1 & weight-loss drug ecosystem (actively managed), not a broad market index.
What is OZEM's expense ratio?
OZEM's expense ratio is 0.59%.
When does OZEM pay a dividend?
OZEM pays annual. The last dividend was $0.409914. The last ex-dividend date was 12/30/2025. It was paid on 12/31/2025.
How has OZEM performed?
Total return is 10.6% over the past 2.1 years, 35.6 points behind SPY at 46.2%. Over the past year its total return — price change plus distributions reinvested — is 6.4%. Its deepest 1-year drawdown was 19.5%.
Is OZEM a good investment?
OZEM's Dividend Vision Distribution Safety Score is 50 (Unproven). That is a risk signal, not investment advice. Compare peers below rather than treating any single figure as a buy or sell.
More securities from Roundhill Investments.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.